These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 32933759)
1. Impact of radiation source activity on short- and long-term outcomes of cervical carcinoma patients treated with high-dose-rate brachytherapy: A retrospective cohort study. Li C; Li X; You J; Liang B; Su X; Huang Y; Chen Y; Hu Q; Deng J; Wang H; Pu Y; Liu H; Ma Y; Wang W; Wu H; Zhang Y Gynecol Oncol; 2020 Nov; 159(2):365-372. PubMed ID: 32933759 [TBL] [Abstract][Full Text] [Related]
2. Efficacy of high-dose-rate brachytherapy with different radiation source activities among cervical cancer patients and risk factors for long-term outcomes: A 6-year retrospective study. Wen F; Li C; Liang B; You J; Li X; Wang J; Liu H; Wang F; Dong Z; Zhang Y Brachytherapy; 2024; 23(1):35-44. PubMed ID: 37919124 [TBL] [Abstract][Full Text] [Related]
4. Definitive radiotherapy based on HDR brachytherapy with iridium 192 in uterine cervix carcinoma: report on the Vienna University Hospital findings (1993-1997) compared to the preceding period in the context of ICRU 38 recommendations. Pötter R; Knocke TH; Fellner C; Baldass M; Reinthaller A; Kucera H Cancer Radiother; 2000; 4(2):159-72. PubMed ID: 10812362 [TBL] [Abstract][Full Text] [Related]
5. High-dose-rate versus low-dose-rate brachytherapy in the treatment of cervical cancer: analysis of tumor recurrence--the University of Wisconsin experience. Petereit DG; Sarkaria JN; Potter DM; Schink JC Int J Radiat Oncol Biol Phys; 1999 Dec; 45(5):1267-74. PubMed ID: 10613322 [TBL] [Abstract][Full Text] [Related]
6. High dose rate cobalt-60 afterloading intracavitary therapy of uterine cervical carcinomas in Srinagarind hospital - analysis of complications. Pesee M; Krusun S; Padoongcharoen P Asian Pac J Cancer Prev; 2010; 11(2):491-4. PubMed ID: 20843138 [TBL] [Abstract][Full Text] [Related]
7. Low-dose-rate vs. high-dose-rate intracavitary brachytherapy for carcinoma of the cervix: The University of Alabama at Birmingham (UAB) experience. Falkenberg E; Kim RY; Meleth S; De Los Santos J; Spencer S Brachytherapy; 2006; 5(1):49-55. PubMed ID: 16563997 [TBL] [Abstract][Full Text] [Related]
8. HDR and MDR intracavitary treatment for carcinoma of the uterine cervix. A prospective randomized study. el-Baradie M; Inoue T; Inoue T; Murayama S; Tang JT; Yamazaki H; Fournier-Bidoz N Strahlenther Onkol; 1997 Mar; 173(3):155-62. PubMed ID: 9122857 [TBL] [Abstract][Full Text] [Related]
9. High-dose versus low-dose rate brachytherapy in definitive radiotherapy of cervical cancer. Kucera H; Pötter R; Knocke TH; Baldass M; Kucera E Wien Klin Wochenschr; 2001 Jan; 113(1-2):58-62. PubMed ID: 11233470 [TBL] [Abstract][Full Text] [Related]
10. Prospective study of HDR (192Ir) versus MDR (137Cs) intracavitary brachytherapy for carcinoma of the uterine cervix. Tanaka E; Oh RJ; Yamada Y; Shiomi H; Nakamura S; Shimamoto S; Teshima T; Inoue T; Inoue T Brachytherapy; 2003; 2(2):85-90. PubMed ID: 15062145 [TBL] [Abstract][Full Text] [Related]
11. Comparison of low and high dose rate brachytherapy in the treatment of uterine cervix cancer. Retrospective analysis of two sequential series. Ferrigno R; Nishimoto IN; Novaes PE; Pellizzon AC; Maia MA; Fogarolli RC; Salvajoli JV Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1108-16. PubMed ID: 15990016 [TBL] [Abstract][Full Text] [Related]
12. High-dose-rate brachytherapy at 14 Gy per hour to point A: preliminary results of a prospectively designed schedule for cancer of the cervix based on the linear-quadratic model. Leborgne F; Leborgne JH; Zubizarreta E; Fowler JF; Maisonneuve J; Ferrari D; Curochquin R Int J Gynecol Cancer; 2001; 11(6):445-53. PubMed ID: 11906547 [TBL] [Abstract][Full Text] [Related]
13. Dose rate correction in medium dose rate brachytherapy for carcinoma cervix. Patel FD; Negi PS; Sharma SC; Kapoor R; Singh DP; Ghoshal S Radiother Oncol; 1998 Dec; 49(3):317-23. PubMed ID: 10075265 [TBL] [Abstract][Full Text] [Related]
14. High dose rate versus low dose rate intracavity brachytherapy for locally advanced uterine cervix cancer. Wang X; Liu R; Ma B; Yang K; Tian J; Jiang L; Bai ZG; Hao XY; Wang J; Li J; Sun SL; Yin H Cochrane Database Syst Rev; 2010 Jul; (7):CD007563. PubMed ID: 20614461 [TBL] [Abstract][Full Text] [Related]
15. Phase III randomized trial comparing LDR and HDR brachytherapy in treatment of cervical carcinoma. Lertsanguansinchai P; Lertbutsayanukul C; Shotelersuk K; Khorprasert C; Rojpornpradit P; Chottetanaprasith T; Srisuthep A; Suriyapee S; Jumpangern C; Tresukosol D; Charoonsantikul C Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1424-31. PubMed ID: 15275728 [TBL] [Abstract][Full Text] [Related]
16. Treatment outcomes of high-dose-rate intracavitary brachytherapy for cervical cancer: a comparison of Ir-192 versus Co-60 sources. Tantivatana T; Rongsriyam K J Gynecol Oncol; 2018 Sep; 29(5):e86. PubMed ID: 30049023 [TBL] [Abstract][Full Text] [Related]